MedTrace Logo

Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry

NCT05106322 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2024-06-26

No results posted yet for this study

Summary

The goal is to have a small spectrometer (pocket size) , reliable and rapid tool that can be used during liver harvesting, which enables macrosteatosis to be evaluated reproducibly and selectively, at any time.

This tool must be minimally invasive, inexpensive and without significantly impacting the general organization of multi-organ harvesting.

In the operating room, the surgeon will perform an intraoperative spectrometer scan (five scans on the left lobe) before clamping the aorta. The surgeon will not be informed of the results of the spectrometer, and will carry out (or not) the biopsy. The spectrometers' results will be compared with definitive histological findings.

Conditions

  • Liver Transplants

Interventions

OTHER

intraoperative spectrometer scan

intraoperative spectrometer scan (five scans on the left lobe) before clamping the aorta

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Nicolas GOLSE · APHP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-14
Primary Completion
2024-11-14
Completion
2024-11-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05106322 on ClinicalTrials.gov